We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Biosensing Platform Detects Bacterial Pneumonia

By LabMedica International staff writers
Posted on 05 Jan 2011
A technique has been developed that will diagnose and differentiate the organisms that cause pneumonia using nanotechnology.

The method combined the existing technology of surface-enhanced Raman spectroscopy (SERS) with silver nanorods to identify different strains of Mycoplasma pneumoniae. More...
Raman spectroscopy works by detecting spectral signatures of a near-infrared laser as it scatters off a biological specimen.

Scientists at the University of Georgia (UGA; Athens, GA, USA), were able to detect and differentiate M. pneumoniae strains from throat swabs. They equated the nanorod array system to a brush with densely packed bristles, where each of the tiny silver rods extends out at a specific angle. The sample, such as bacteria from a throat swab, penetrates among the bristles, where the spectral signature produced by the laser is amplified and then analyzed by a computer program.

Clinical throat swab samples, collected from the University of Alabama (Birmingham, AL, USA), were processed by extraction and subsequently tested by polymerase chain reaction (PCR). Three M. pneumoniae strains were reproducibly differentiated by nanorod-SERS (NA-SERS), with 95%–100% specificity and 94%–100% sensitivity, and with a lower detection limit exceeding standard PCR. In addition, NA-SERS correctly classified with greater than 97% accuracy, 10 true clinical throat swab samples previously established by real-time PCR and culture to be positive or negative for M. pneumoniae.

Duncan C. Krause, PhD, a professor of microbiology at UGA, said, "If you can make a positive identification from a 10-minute test, then appropriate antibiotics can be prescribed, limiting both the consequences in that patient and the likelihood that it will spread to others. The device can be reduced to a size that could fit in a briefcase, although testing is currently done only in a laboratory setting. Our hope is that when we begin to explore the capabilities of this technology, it can be applied in point-of-care testing. Then the impact becomes truly significant."

Infections due to M. pneumoniae are very common yet difficult to diagnose. The bacterium is a major cause of respiratory disease in humans accounting for 20% of all community-acquired pneumonia and the leading cause of pneumonia in older children and young adults. It can cause permanent damage to the lungs if not diagnosed promptly. A delay in diagnosis extends the likelihood for complications as well as continued transmission to the community. The study was published online December 2010 in PLoS One.

Related Links:

University of Georgia
University of Alabama



New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Automated Biochemical Analyzer
iBC 900
New
Anterior Nasal Specimen Collection Swabs
53-1195-TFS, 53-0100-TFS, 53-0101-TFS, 53-4582-TFS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: The 3D paper-based analytical device has shown high clinical accuracy for adult-onset immunodeficiency (Photo courtesy of National Taiwan University)

Paper-Based Device Accurately Detects Immune Defects in 10 Minutes

Patients with hidden immune defects are especially vulnerable to severe and persistent infections, often due to autoantibodies that block interferon-gamma (IFN-γ), a key molecule in immune defense.... Read more

Pathology

view channel
Image: Researchers have developed a novel method to analyze tumor growth rates (Photo courtesy of Adobe Stock)

Novel Method To Analyze Tumor Growth Rates Helps Tracks Progression Between Diagnosis and Surgery

Patients diagnosed with breast cancer often worry about how quickly their tumors grow while they wait for surgery, and whether delays in treatment might allow the disease to spread beyond the point of cure.... Read more

Technology

view channel
Image: The newly designed ExoPatch successfully distinguished melanoma from healthy skin in mice (Photo courtesy of Jeremy Little/Michigan Engineering)

Microneedle Skin Patch Detects Melanoma Without Biopsy or Blood Draw

Melanoma, the most aggressive form of skin cancer, currently requires patients, especially those with fair skin and moles, to undergo regular doctor visits and biopsies every six months to determine if... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.